4.5 Review

Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2007.07.045

关键词

myosin heavy chain expression; cardiac hypertrophy; heart failure; thyroid hormone; adrenergic receptors; chromatin-remodeling enzymes

资金

  1. NHLBI NIH HHS [R01 HL068083, R01 HL83423, R01 HL77788, R01 HL-68083, R01 HL083423-01A1, R01 HL068083-03, R01 HL077788-04, R01 HL083423, R01 HL077788, R01 HL077788-03] Funding Source: Medline

向作者/读者索取更多资源

Myosin is a molecular motor, which interacts with actin to convert the energy from ATP hydrolysis into mechanical work. In cardiac myocytes, two myosin isoforms are expressed and their relative distribution changes in different developmental and pathophysio logic conditions of the heart. It has been realized for a long time that a shift in myosin isoforms plays a major role in regulating myocardial contractile activity. With the recent evidence implicating that alteration in myosin isoform ratio may be eventually beneficial for the treatment of a stressed heart, a new interest has developed to find out ways of controlling the myosin isoform shift. This article reviews the published data describing the role of myosin isoforms in the heart and highlighting the importance of various factors shown to influence myosin isofrom shift during physiology and disease states of the heart. (C) 2007 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据